Tse KF - Search Results

1

Treatment parameters modulating regression of human melanoma xenografts by an antibody-drug conjugate (CR011-vcMMAE) targeting GPNMB.

Pollack VA, Alvarez E, Tse KF, Torgov MY, Xie S, Shenoy SG, MacDougall JR, Arrol S, Zhong H, Gerwien RW, Hahne WF, Senter PD, Jeffers ME, Lichenstein HS, LaRochelle WJ. Pollack VA, et al. Among authors: tse kf. Cancer Chemother Pharmacol. 2007 Aug;60(3):423-35. doi: 10.1007/s00280-007-0490-z. Epub 2007 Jun 1. Cancer Chemother Pharmacol. 2007. PMID: 17541593

2

CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma.

Tse KF, Jeffers M, Pollack VA, McCabe DA, Shadish ML, Khramtsov NV, Hackett CS, Shenoy SG, Kuang B, Boldog FL, MacDougall JR, Rastelli L, Herrmann J, Gallo M, Gazit-Bornstein G, Senter PD, Meyer DL, Lichenstein HS, LaRochelle WJ. Tse KF, et al. Clin Cancer Res. 2006 Feb 15;12(4):1373-82. doi: 10.1158/1078-0432.CCR-05-2018. Clin Cancer Res. 2006. PMID: 16489096

3

Basic fibroblast growth factor (bFGF) and its receptor expression (bek and flg) In bone marrow stroma of murine AIDS.

Tse KF, Inayat MS, Morrow JK, DellaPuca R, Hughes NK, Gallicchio VS. Tse KF, et al. Virus Res. 2004 May;101(2):175-84. doi: 10.1016/j.virusres.2004.01.007. Virus Res. 2004. PMID: 15041185

4

Reconstitution of erythroid, megakaryocyte and myeloid hematopoietic support function with neutralizing antibodies against IL-4 and TGFbeta1 in long-term bone marrow cultures infected with LP-BM5 murine leukemia virus.

Tse KF, Inayat MS, Morrow JK, Hughes NK, Oakley OR, Gallicchio VS. Tse KF, et al. Virus Res. 2005 Oct;113(1):1-15. doi: 10.1016/j.virusres.2005.03.027. Virus Res. 2005. PMID: 15869820

5

Stromal cell lines derived from LP-BM5 murine leukemia virus-infected long-term bone marrow cultures impair hematopoiesis in vitro.

Tse KF, Morrow JK, Hughes NK, Gallicchio VS. Tse KF, et al. Blood. 1994 Sep 1;84(5):1508-18. Blood. 1994. PMID: 7520775 Free article.

6

Effect of lithium in immunodeficiency: improved blood cell formation in mice with decreased hematopoiesis as the result of LP-BM5 MuLV infection.

Gallicchio VS, Hughes NK, Tse KF, Ling J, Birch NJ. Gallicchio VS, et al. Among authors: tse kf. Antiviral Res. 1995 Mar;26(2):189-202. doi: 10.1016/0166-3542(94)00075-j. Antiviral Res. 1995. PMID: 7605115

7

Effect of combination interleukin-1 and erythropoietin in ameliorating the hematopoietic toxicity associated with the use of zidovudine administered to normal mice.

Gallicchio VS, Hughes NK, Tse KF, Gaines H. Gallicchio VS, et al. Among authors: tse kf. Life Sci. 1994;54(20):PL351-61. doi: 10.1016/0024-3205(94)90023-x. Life Sci. 1994. PMID: 8190019

8

Effect of lithium in murine immunodeficiency virus infected animals.

Gallicchio VS, Cibull ML, Hughes NK, Tse KF. Gallicchio VS, et al. Among authors: tse kf. Pathobiology. 1993;61(3-4):216-21. doi: 10.1159/000163797. Pathobiology. 1993. PMID: 8216844

9

Failure to establish long-term marrow cultures from immunodeficient mice (MAIDS): effect of zidovudine in vitro.

Tse KF, Hughes NK, Gallicchio VS. Tse KF, et al. J Leukoc Biol. 1993 Jun;53(6):658-65. doi: 10.1002/jlb.53.6.658. J Leukoc Biol. 1993. PMID: 8315348

10

Sustained zidovudine treatment on hematopoiesis in immunodeficient mice.

Gallicchio VS, Hughes NK, Tse KF. Gallicchio VS, et al. Among authors: tse kf. Int J Immunopharmacol. 1993 Aug;15(6):673-81. doi: 10.1016/0192-0561(93)90140-t. Int J Immunopharmacol. 1993. PMID: 8407052

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page